European Fine Chemicals Markets - Investment Analysis and Growth OpportunitiesFrost & SullivanJuly 26, 2006 SKU: MC1393107 |
|
Research Report on Chinese Bio-pharmaceutical Industry, 2012
3/21/2012 | published by: China Research and Intelligence Co., Ltd.
In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). In China, animal vaccine belongs to veterinary medicine rather than
|
more...
|
$3,000.00
|
|
The US Pharmaceutical Market Outlook to 2016 - Evolving Opportunities in the Biologics Segment
3/1/2012 | published by: AM Mindpower Solutions
EXECUTIVE SUMMARY The report titled “The US Pharmaceutical Market Outlook to 2015 – Evolving Opportunities in the Biologics Segment” provides a comprehensive analysis on the Pharmaceutical market in the US covering various aspects such as market
|
more...
|
$850.00
|
|
Global Biosimilars Market Forecast to 2015
3/1/2012 | published by: RNCOS
The biosimilars industry has been growing stupendously across the globe for past few years. Increasing healthcare costs and rising aging population are driving the industry, which stands at a vivid position and is expected to
|
more...
|
$1,500.00
|
|
Biologics Market in Brazil
3/2/2012 | published by: Frost & Sullivan
This research service considers the biologics market in Brazil. It covers the market’s move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, blood factors, insulin, filgrastim, interferon,
|
more...
|
$6,000.00
|
|
Biosimilars: Current Situation & Future Prospects, Worldwide
3/1/2012 | published by: JustPharmaReports.com
The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry. On this basis, prospects for biosimilars look good, with the vast majority of leading originator brands in the global
|
more...
|
$3,000.00
|
|
Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition
10/15/2011 | published by: Kalorama Information
Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the
|
more...
|
$3,500.00
|
|
Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccines and Biologics
7/1/2011 | published by: Kalorama Information
As researchers work to improve drug properties through drug design and molecular modeling, the line between drug delivery and drug substance will become more and more elusive in the near future, as shown in the
|
more...
|
$2,995.00
|
|
Biologicals in Oncology Drug Pipeline Update 2012
2/21/2012 | published by: BioSeeker Group AB
This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies.There are today 669 companies plus partners developing 1071 biological drugs in 2294 developmental projects in
|
more...
|
$3,749.00
|
|
World Biological Drugs Market 2012-2022
2/14/2012 | published by: Visiongain
Where is the market for biological drugs heading? Visiongain's report shows you potential revenues to 2022, with data, forecasts and discussions.
Our new study investigates biotechnology in pharma - biological drugs (biopharmaceuticals,
|
more...
|
$2,642.00
|
|
Analysis of European Biosimilars Market
12/20/2011 | published by: Frost & Sullivan
The aim of this research study is to thoroughly assess and analyse the biosimilars market, as well as market and technology trends in Europe, in order to provide strategic recommendations for the success of market
|
more...
|
$6,500.00
|
Related Markets
Biopharmaceuticals Reports
- Research Report on Chinese Bio-pharmaceutical Industry, 2012
- Regulatory Intelligence on Biologics Recalls – Immunoglobulins and Vaccines are Involved in More Recalls than Other Drug Classes
- Biologics Market in Brazil
- Global Biosimilars Market Forecast to 2015
- Biosimilars: Current Situation & Future Prospects, Worldwide
